Plunkett Research Online: Biomark Diagnostics

BIOMARK DIAGNOSTICS (BUX:CNQ) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Biomark Diagnostics Inc is an oncology focused company. The Company is engaged in developing commercialization avenues for cancer detection and monitoring business......



Biomark Diagnostics
Ticker: BUX
Exchange: CNQ
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 604 836-6950
Fax:
Address: 165 - 10551 Shellbridge Way
Richmond, BC V6X 2W8 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Medical Laboratories
ContactsDescription

Biomark Diagnostics Inc is an oncology focused company. The Company is engaged in developing commercialization avenues for cancer detection and monitoring business......See More See More

Auditor:
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: